Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Sorrento Therapeutics Inc (SRNE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0160 -0.0040    -20.00%
16:09:00 - Delayed Data. Currency in USD ( Disclaimer )
  • Volume: 22,214
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0160 - 0.0200
Type:  Equity
Market:  United States
Sorrento Therapeutics Inc 0.0160 -0.0040 -20.00%

OTC:SRNE Financials

 
This summary provides an overview of the most significant critical numbers from each of the Sorrento Therapeutics Inc financial reports, including theSorrento Therapeutics Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the OTC:SRNE financials over time via breakdowns of their annual reports.

Sorrento Therapeutics, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was USD 15.03 million compared to USD 11.46 million a year ago. Net loss was USD 95.21 million compared to USD 218.76 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.54 a year ago. Diluted loss per share from continuing operations was USD 0.17 compared to USD 0.54 a year ago.For the six months, revenue was USD 31.28 million compared to USD 29.85 million a year ago. Net loss was USD 234.73 million compared to USD 259.57 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.7 a year ago. Diluted loss per share from continuing operations was USD 0.43 compared to USD 0.7 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

SRNE Income Statement & Profits

Gross margin TTM -245.01%
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Revenue 15.02 16.25 15.59 17.4
Gross Profit -26.7 -32.74 -39.17 -58.86
Operating Income -76.77 -88.85 -79.76 -110.14
Net Income -95.21 -139.62 -223.69 -89.58

SRNE Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ 0.4
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Total Assets 456.69 460.06 472.84 615.61
Total Liabilities 654.65 587.48 494.51 485.41
Total Equity -197.96 -127.42 -21.67 130.21

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -16.92%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -55.66 -49.46 -68.34 -61.17
Cash From Investing Activities -0.14 1.68 -5.03 -8.09
Cash From Financing Activities 88.81 61.2 25.08 71.5
Net Change in Cash 32.09 14.02 -47.05 0.341
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SRNE Price Commentary

Write your thoughts about Sorrento Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
DPP TCR
DPP TCR Apr 01, 2022 16:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2.30 and down again yeesh!
Iggy Maldon
Iggy Maldon Oct 05, 2021 19:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
General selloff due to mercks anti covid pill. Major blast for smaller stocks. As soon as main portfolio comes back to the scene it should rerate again
Gyorgy Hnatyszyn
Gyorgy Hnatyszyn Oct 01, 2021 17:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened? Any ideas?
Emil Gospodinov
Emil Gospodinov Jul 26, 2021 10:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The chart hete has gone crazy. 🤣
Ko Wei Ann
Ko Wei Ann Jul 26, 2021 10:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ikr. plus 300 percent
Ko Wei Ann
Ko Wei Ann Jul 26, 2021 10:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it is reading pre-market 300+ percent up
Alan Stastny
Alan Stastny Jul 07, 2021 17:05
Saved. See Saved Items.
This comment has already been saved in your Saved Items
******stock
Iggy Maldon
Iggy Maldon Jun 07, 2021 17:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya
Carton Filip
Carton Filip Jun 07, 2021 17:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
great implosion
Iggy Maldon
Iggy Maldon May 26, 2021 18:33
Saved. See Saved Items.
This comment has already been saved in your Saved Items
About to implode
Lissa Haughton
Lissa Haughton May 17, 2021 12:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What is happening with SRNE
Beebs Elite
Beebs Elite Mar 25, 2021 19:57
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Easy buy here
Iving Iving
Iving Iving Mar 12, 2021 16:07
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Isn't it a quick sand stock ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email